MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma (NHL). Patients with DLBCL harboring MYC aberrations concurrent with BCL2 or/and BCL6 aberrations constitute a specific group with extremely poor outcome. In this study, we retrospectively investigated the incidence and pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Ting-Xun, Fan, Lei, Wang, Li, Wu, Jia-Zhu, Miao, Kou-Rong, Liang, Jin-Hua, Gong, Qi-Xing, Wang, Zhen, Young, Ken H., Xu, Wei, Zhang, Zhi-Hong, Li, Jian-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621897/
https://www.ncbi.nlm.nih.gov/pubmed/26158410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621897/
https://www.ncbi.nlm.nih.gov/pubmed/26158410

Ejemplares similares